Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive'

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would back Moderna, Inc. MRNA here. "I think that Stephane Bancel is the real deal," he added.

Cramer recommended holding onto BioNTech SE BNTX. "I don’t understand why it’s so inexpensive," he noted.

When asked about Amphastar Pharmaceuticals, Inc. AMPH, he said, "This was part of one of these situations where once, once the pandemic was over, people just don’t want it anymore. I don’t know. I mean, to me, I want you in Becton, Dickinson and Company BDX, let’s put it that way. You won’t have that kind of up and down thing."

Don’t forget to check out our premarket coverage here

The "Mad Money" host said Pan American Silver Corp. PAAS is the "best one" of the silver companies.

When asked about Starwood Property Trust, Inc. STWD, he said, "That’s Barry Sternlicht, and, you know what, I’m willing to take his dividend and wait for that turn."

"Just buy it," Cramer said about Lockheed Martin Corporation LMT.

Price Action: Shares of Lockheed Martin fell 1.2% to close at $457.84, while Starwood Property Trust fell 1.7% to $20.46 on Tuesday. Pan American Silver fell 5.2% to settle at $14.68, while Becton, Dickinson shares slipped 0.5% to close at $235.00 during Tuesday’s session. Amphastar Pharmaceuticals gained 2.4% to $55.50, while BioNTech fell 3.9% to settle at $99.57. Moderna shares declined 3.6% to close at $102.16 on Tuesday.

Now Read This: Nvidia, CrowdStrike And 2 Other Stocks Insiders Are Selling

Photo: Shutterstock